Works matching DE "BLOCKING antibodies"


Results: 99
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression.

    Published in:
    2018
    By:
    • Yawara Kawano;
    • Zavidij, Oksana;
    • Park, Jihye;
    • Moschetta, Michele;
    • Katsutoshi Kokubun;
    • Mouhieddine, Tarek H.;
    • Manier, Salomon;
    • Yuji Mishima;
    • Naoka Murakami;
    • Bustoros, Mark;
    • Pistofidis, Romanos Sklavenitis;
    • Reidy, Mairead;
    • Yu J. Shen;
    • Rahmat, Mahshid;
    • Lukyanchykov, Pavlo;
    • Karreci, Esilida Sula;
    • Shokichi Tsukamoto;
    • Jiantao Shi;
    • Satoshi Takagi;
    • Huynh, Daisy
    Publication type:
    journal article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo.

    Published in:
    Science Translational Medicine, 2018, v. 10, n. 450, p. 1, doi. 10.1126/scitranslmed.aam7710
    By:
    • Richmond, Jillian M.;
    • Strassner, James P.;
    • Zapata, Lucio;
    • Garg, Madhuri;
    • Riding, Rebecca L.;
    • Refat, Maggi A.;
    • Fan, Xueli;
    • Azzolino, Vincent;
    • Tovar-Garza, Andrea;
    • Tsurushita, Naoya;
    • Pandya, Amit G.;
    • Tso, J. Yun;
    • Harris, John E.
    Publication type:
    Article
    29
    30
    31
    32

    Genetically Blocking the Zebrafish Pineal Clock Affects Circadian Behavior.

    Published in:
    PLoS Genetics, 2016, v. 12, n. 11, p. 1, doi. 10.1371/journal.pgen.1006445
    By:
    • Ben-Moshe Livne, Zohar;
    • Alon, Shahar;
    • Vallone, Daniela;
    • Bayleyen, Yared;
    • Tovin, Adi;
    • Shainer, Inbal;
    • Nisembaum, Laura G.;
    • Aviram, Idit;
    • Smadja-Storz, Sima;
    • Fuentes, Michael;
    • Falcón, Jack;
    • Eisenberg, Eli;
    • Klein, David C.;
    • Burgess, Harold A.;
    • Foulkes, Nicholas S.;
    • Gothilf, Yoav
    Publication type:
    Article
    33
    34

    Center practice drives variation in choice of US kidney transplant induction therapy: a retrospective analysis of contemporary practice.

    Published in:
    Transplant International, 2018, v. 31, n. 2, p. 198, doi. 10.1111/tri.13079
    By:
    • Dharnidharka, Vikas R.;
    • Naik, Abhijit S.;
    • Axelrod, David A.;
    • Schnitzler, Mark A.;
    • Zhang, Zidong;
    • Bae, Sunjae;
    • Segev, Dorry L.;
    • Brennan, Daniel C.;
    • Alhamad, Tarek;
    • Ouseph, Rosemary;
    • Lam, Ngan N.;
    • Nazzal, Mustafa;
    • Randall, Henry;
    • Kasiske, Bertram L.;
    • McAdams‐Demarco, Mara;
    • Lentine, Krista L.
    Publication type:
    Article
    35
    36
    37
    38

    Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice.

    Published in:
    Cancers, 2019, v. 11, n. 11, p. 1689, doi. 10.3390/cancers11111689
    By:
    • Giannini, Edoardo G.;
    • Aglitti, Andrea;
    • Borzio, Mauro;
    • Gambato, Martina;
    • Guarino, Maria;
    • Iavarone, Massimo;
    • Lai, Quirino;
    • Levi Sandri, Giovanni Battista;
    • Melandro, Fabio;
    • Morisco, Filomena;
    • Ponziani, Francesca Romana;
    • Rendina, Maria;
    • Russo, Francesco Paolo;
    • Sacco, Rodolfo;
    • Viganò, Mauro;
    • Vitale, Alessandro;
    • Trevisani, Franco
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    Metastasis: New recruits.

    Published in:
    Nature Reviews Cancer, 2011, v. 11, n. 7, p. 462, doi. 10.1038/nrc3100
    By:
    • Seton-Rogers, Sarah
    Publication type:
    Article
    49
    50